CNBC Squawk Box April 23, 2012
the company's closing price and gives them a new drug to bolster its pipeline. also amlin spurped a takeover bid from bristol-myers and is fending off a lawsuit by carl icahn. >> i like did today. we haven't seen this in a while. i don't know if you consider this the pharmaceutical sector when you start thinking about baby infor formula. >> why do they need the cash? >> pfizer has become a bloated big old mess. >> so they get all this money -- >> they'll use it for research and probably see it in divide dividends. largest story is pfizer trying to get its act together. some people th...